₹25.77
−4.34%NSE close, 16 Nov 2026
+85.13%
Anlon Healthcare is a small cap company, listed on NSE under the symbol AHCL. At ₹25.77 a share, the market values the whole company at ₹1,370 crore.
In FY26, it reported sales of ₹172 crore and a net profit of ₹29 crore, an operating margin of 27.6%.
The market values the company at 36.7 times its profit over the last twelve months and 5.32 times its book value; its return on equity is 14.5% and its borrowings are 0.28 times its equity.
Promoters hold 52.68% of the shares. Foreign institutions hold 1.00%, and domestic institutions, mutual funds among them, 0.30%.
Over the past year the share price has risen 84.5%, and it is 30.8% below its 52-week high.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | Jun 2025 S | Sep 2025 S | Dec 2025 S | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Sales | 33.3 | 52.2 | 35.6 | 50.9 | 87.6 |
Transcript
Link of Recording
Hereby submit the Unaudited Standalone and Consolidated Financial Results of the Company as set out in compliance with Indian Accounting Standards ("IND AS") for the quarter and half year ended September 30, 2026; together with the Limited Review Report of the Auditor's thereon
| Expenses | 27.1 | 38.5 | 23.2 | 35.6 | 72.0 | 80.4 |
|---|
| Operating profit | 6.2 | 13.7 | 12.3 | 15.3 | 15.6 | 25.2 |
|---|
| Operating margin | 18.7% | 26.3% | 34.7% | 30.0% | 17.8% | 23.9% |
|---|
| Other income | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.1 |
|---|
| Interest | 0.8 | 0.9 | 1.6 | 0.6 | 0.9 | 0.9 |
|---|
| Depreciation | 0.4 | 0.5 | 0.4 | 0.3 | 1.1 | 1.0 |
|---|
| Profit before tax | 5.0 | 12.5 | 10.6 | 14.4 | 13.7 | 23.5 |
|---|
| Tax | 1.5 | 3.1 | 5.5 | 3.4 | 5.4 | 6.3 |
|---|
| Net profit | 3.6 | 9.3 | 5.2 | 10.5 | 8.3 | 13.4 |
|---|
| EPS (₹) | 4.44 | 2.22 | 1.13 | 2.33 | 0.16 | 0.32 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 172 |
| Expenses | 124 |
| Operating profit | 47.5 |
| Operating margin | 27.6% |
| Other income | 0.3 |
| Interest | 3.7 |
| Depreciation | 1.5 |
| Profit before tax | 42.5 |
| Tax | 13.4 |
| Net profit | 28.5 |
| EPS (₹) | 6.11 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | −79.4 | −7.9 |
| From investing | −36.3 | −28.5 |
| From financing | 119 | 39.4 |
| Spent on fixed assets | 0 | −28.0 |
| Free cash flow | −79.4 | −35.9 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 16.6% |
| Operating margin | 27.6% |
| Return on equity | 12.4% |
| Return on capital employed | 16.9% |
| Return on assets | 7.6% |
| Debt to equity | 0.19 |
| Interest coverage | 12.40 |
| Debt to assets | 0.12 |
| Current ratio | 2.87 |
| Quick ratio | 1.81 |
| Cash ratio | 0.04 |
| Asset turnover | 0.46 |
| Fixed asset turnover | 2.98 |
| Inventory turnover | 0.90 |
| Receivables turnover | 1.70 |
| Gross margin | 38.9% |
| Cash from operations to profit | -279.0% |
| Effective tax rate | 31.6% |
The financial results for the period ended September 30, 2026.
Intimation of receipt of 'In-Principle' Approval under Regulation 30 of SEBI (LODR) Regulations, 2015
Schedule of meet
SDD Compliance Certificate as per Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
Outcome of Board Meeting held on October 13, 2026.
Has informed regarding Disclosure of material issue
Has informed regarding Disclosure of material issue
Significant movement in price has been observed in Anlon Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to…
Significant movement in price has been observed in Anlon Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to…